Table 2.

Medication duration and adverse reactions of treatment in the BTM monitoring group and the control group

	Monitoring group (n = 28)	Control group (n = 29)	p value
Alendronate duration (days)	236 ± 71	90 ± 0	0.000
Calcitriol + Ca duration (days)	214 ± 72	90 ± 0	0.000
Total medication duration (days)	259 ± 72	90 ± 0	0.000
Adverse reaction	5 (17.9%)a	2 (6.9%)b	0.392

Ca calcium

^aThree patients had gastrointestinal reaction and two patients had muscular soreness

^bOne patient had gastrointestinal reaction and one patient had headache